Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.

Goodwin PJ, Stambolic V, Lemieux J, Chen BE, Parulekar WR, Gelmon KA, Hershman DL, Hobday TJ, Ligibel JA, Mayer IA, Pritchard KI, Whelan TJ, Rastogi P, Shepherd LE
Breast Cancer Res Treat. 2011 126 (1): 215-20

PMID: 20976543 · DOI:10.1007/s10549-010-1224-1

MeSH Terms (10)

Antineoplastic Agents Breast Neoplasms Clinical Trials, Phase III as Topic Diabetes Mellitus, Type 2 Evaluation Studies as Topic Female Humans Hypoglycemic Agents Metformin Prognosis

Connections (1)

This publication is referenced by other Labnodes entities: